Outcomes after radical prostatectomy for cancer: A comparison between general anesthesia and epidural anesthesia with fentanyl analgesia: A matched cohort study

Anesthesia and Analgesia

Volumn 119, Issue 4, 2014, Pages 859-866

  Sprung, Juraj ^a   Scavonetto, Federica ^a   Yeoh, Tze Yeng ^a,b   Kramer, Jessica M ^a,c   Jeffrey Karnes, R ^d   Eisenach, John H ^a   Schroeder, Darrell R ^a   Weingarten, Toby N ^a  

^a MAYO CLINIC   (United States)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c Midwest Anesthesiologists PA   (United States)

^d Departmentof Urology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; ISOFLURANE; MIDAZOLAM; MORPHINE; OXYCODONE; OXYMORPHONE;

ADULT; ANALGESIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; TUMOR GROWTH; AGED; COMPARATIVE STUDY; FOLLOW UP; PROSTATIC NEOPLASMS; REGISTER; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TRENDS;

AGED; ANESTHESIA, EPIDURAL; ANESTHESIA, GENERAL; COHORT STUDIES; FENTANYL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84914118652     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000320     Document Type: Article

References (40)

1. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001;94:1066-73
2. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999;80:880-8
3. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010;105:106-15
4. Holmgren L, O'Reilly MS, Folkman J. Dormancy of microme-tastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-53
5. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Signifcant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58-65
6. Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, Ruud E, Truchaud A, Lustenberger P. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 1997;74:540-4
7. Welters ID. Is immunomodulation by opioid drugs of clinical relevance? Curr Opin Anaesthesiol 2003;16:509-13
8. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 2001;62:111-23
9. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther 2004;11:354-65
10. Pollock RE, Lotzová E. Surgical-stress-related suppression of natural killer cell activity: a possible role in tumor metastasis. Nat Immun Cell Growth Regul 1987;6:269-78
11. Brand JM, Kirchner H, Poppe C, Schmucker P. The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol 1997;83:190-4
12. Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J, Guyre PM. Morphine inhibits spontaneous and cyto-kine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995;83:500-8
13. Shapiro J, Jersky J, Katzav S, Feldman M, Segal S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest 1981;68:678-85
14. Markovic SN, Knight PR, Murasko DM. Inhibition of inter-feron stimulation of natural killer cell activity in mice anesthetized with halothane or isofurane. Anesthesiology 1993;78:700-6
15. Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg 2006;102:1103-7
16. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008;109:180-7
17. Scavonetto F, Yeoh TY, Umbreit EC, Weingarten TN, Gettman MT, Frank I, Boorjian SA, Karnes RJ, Schroeder DR, Rangel LJ, Hanson AC, Hofer RE, Sessler DI, Sprung J. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. Br J Anaesth 2013 [Epub ahead of print]
18. Sandler AN, Stringer D, Panos L, Badner N, Friedlander M, Koren G, Katz J, Klein J. A randomized, double-blind comparison of lumbar epidural and intravenous fentanyl infusions for postthoracotomy pain relief. Analgesic, pharmacokinetic, and respiratory effects. Anesthesiology 1992;77:626-34
19. Peng PW, Sandler AN. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 1999;90:576-99
20. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP. AJCC cancer staging manual. In: American Joint Committee on Cancer, 5th ed. Philadelphia, PA: Lippincott-Raven, 1997
21. Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Defning prostate specifc antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 2001;165:1146-51
22. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workfow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81
23. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. Skokie, IL: American Pain Society, 1999
24. McPherson ML. Demystifying Opioid Conversion Calculations: A Guide to Effective Dosing. American Society of Health Sytem Pharmacists, 2009:161
25. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41
26. Yeager MP, Rosenkranz KM. Cancer recurrence after surgery: a role for regional anesthesia? Reg Anesth Pain Med 2010;35:483-4
27. Sessler DI. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur J Cancer Prev 2008;17:269-72
28. Sessler DI. Long-term consequences of anesthetic management. Anesthesiology 2009;111:1-4
29. Sessler DI. Regional anesthesia and prostate cancer recurrence. Can J Anaesth 2010;57:99-102
30. Sessler DI, Ben-Eliyahu S, Mascha EJ, Parat MO, Buggy DJ. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials 2008;29:517-26
31. Menigaux C, Guignard B, Fletcher D, Sessler DI, Levron JC, Chauvin M. More epidural than intravenous sufentanil is required to provide comparable postoperative pain relief. Anesth Analg 2001;93:472-6
32. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, Notti I, Bessler H. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 1996;82:492-7
33. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003;10:972-92
34. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 2008;107:325-32
35. de Oliveira GS Jr, Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 2011;36:271-7
36. Tsui BC, Rashiq S, Schopfocher D, Murtha A, Broemling S, Pillay J, Finucane BT. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 2010;57:107-12
37. Wuethrich PY, Hsu Schmitz SF, Kessler TM, Thalmann GN, Studer UE, Stueber F, Burkhard FC. Potential infuence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 2010;113:570-6
38. Gupta A, Björnsson A, Fredriksson M, Hallböök O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 2011;107:164-70
39. Forget P, Tombal B, Scholtès JL, Nzimbala J, Meulders C, Legrand C, Van Cangh P, Cosyns JP, De Kock M. Do intra-operative analgesics infuence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol 2011;28:830-5
40. Zincke H, Lau W, Bergstralh E, Blute ML. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. J Urol 2001;166:2208-15